Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO Notebook: Policy Uncertainty Constraining Dealmaking

Jun 19 2025

• By Mandy Jackson and Joseph Haas

BIO 2025 Notebook Day 4

Related Content

First Quarter M&A Activity Rose On The Strength Of Three Deals

Apr 10 2025

How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

May 30 2025

‘Clean Sweep’ Of US CDC Vaccine Committee Puts Kennedy In Driver’s Seat

Jun 10 2025

How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

May 30 2025

Novartis Welcomes Abelacimab Back Into The Fold With Anthos Acquisition

Feb 11 2025

BIO Notebook: IPO Window Stays Shut, PRVs Need To Be A Priority, And Focusing On Gene Therapy Safety

Jun 17 2025

AI-Fueled Generate Maps Out Path To Clinic Over Next 24 Months

Sep 14 2023

Amgen Joins AI/ML Gold Rush With Generate Deal

Jan 07 2022

Generate Snares Novartis As Partner/Investor For Its AI/ML Approach

Sep 24 2024

Tezspire Phase III Nasal Polyp Data May Lead To Second Indication

Nov 08 2024

Related Companies

Novartis AG

Anthos Therapeutics Inc.

Amgen, Inc.

Additional Topics

More from BIO

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window